Cagrilintide

Long-acting amylin analogue targeting amylin receptors.

Classification

Synthetic amylin receptor agonist peptide. Cagrilintide is designed to mimic the effects of amylin, a naturally occurring peptide hormone co-secreted with insulin. It belongs to a class of compounds focused on satiety signaling and appetite regulation through pathways distinct from incretin-based therapies.

Target Receptors

• Amylin Receptors – Associated with satiety signaling, gastric-emptying regulation, and food-intake control.

Structure

Cagrilintide is a synthetic analogue of the naturally occurring hormone amylin, engineered with structural modifications to improve stability and duration of action.

Research Focus

Studied for its potential effects on satiety enhancement, hunger reduction, appetite regulation, and metabolic health.